1200 Waterfront Centre
200 Burrard Street
Vancouver, BC V6C 3L6
Canada
866 786 6482
https://www.sunniva.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Anthony F. Holler M.D. | Co-founder, CEO & Chairman of the Board | 248.92k | N/A | 1952 |
Dr. Mark Hamish Kimmins | President of NHS | 3.42M | N/A | 1967 |
Mr. David Weinmann | Global Controller & Interim CFO | N/A | N/A | N/A |
Rob Knowles | Vice President of Corporate Development | N/A | N/A | N/A |
Mr. Jose Calderon | Head of Grower | N/A | N/A | N/A |
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
Sunniva Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.